Baby electrolyte market seen reaching $2.9 billion by 2031

The global baby electrolyte market is projected to nearly triple from 2021 to 2031 as infant diarrhea, greater parental awareness and demand for natural ingredients drive sales. Asia-Pacific led revenue in 2021, while Europe is forecast to grow the fastest over the period.

Why it matters: - Baby electrolyte products are gaining traction as parents look for ways to help manage infant dehydration linked to diarrhea and preterm birth. - The market's growth also reflects rising interest in plant-based and natural ingredients in baby care products. - The report points to a broader shift in infant health spending, including more demand for oral rehydration products and related hydration tools.

What happened: - Allied Market Research estimated the global baby electrolyte market at $1.2 billion in 2021. - The firm projects the market will reach $2.9 billion by 2031. - The report forecasts a 9.4% compound annual growth rate from 2022 to 2031. - The report covers market trends by form, flavor, application, distribution channel and region.

The details: - The market is segmented by form into liquid, powder and other products. - Applications include up to 12 months, 12 to 36 months and 36 to 60 months. - Flavors include grape, apple, strawberry, orange, unflavored and others. - Distribution channels include modern trade and general trade. - Modern trade includes supermarkets and hypermarkets, pharmacy or medical stores, convenience stores and online stores. - General trade includes pharmacy or medical stores, convenience stores and others. - Regional coverage includes North America, Europe, Asia-Pacific and LAMEA. - Key companies listed in the report include Abbott Laboratories, The Hain Celestial Group, Johnson & Johnson, Cipla Ltd., Sanofi, Cera Products, Monico S.p.A., Mead Johnson & Company, Kinderfarms, FDC Limited, Unilab, Prestige Consumer Healthcare, Halewood Laboratories, Goodonya and Otsuka Holdings. - The report includes a sample download, a purchase inquiry page, and linked reports on baby drinks, organic baby food and U.S. baby infant formula.

Between the lines: - Infant diarrhea remains the central demand driver, with the World Health Organization saying diarrhea kills about 525,000 children age 5 or younger each year and accounted for about 9% of global child deaths in 2019. - The report says diarrhea in infants can be linked to antibiotics, dietary changes, bacterial infections, parasite infections and cystic fibrosis. - Stricter government safety rules could restrain growth by raising compliance burdens. - Declining fertility rates may also limit demand. - Smart baby pacifiers could support the market by measuring saliva, tracking salt and potassium levels and alerting healthcare professionals in real time. - The report says conventional hydration checks are slower and more invasive. - The World Health Organization estimates about 15 million babies are born prematurely each year, which could support demand because dehydration is common among preterm infants.

What's next: - Asia-Pacific is expected to remain the largest regional market through 2031 after generating nearly half of global revenue in 2021. - Europe is projected to post the fastest growth at 11.1% CAGR from 2022 to 2031. - The report links Asia-Pacific growth to rising awareness of oral rehydration solutions and higher diarrhea-related mortality among children. - Europe’s growth is tied to stronger demand for natural and organic options with fewer additives and preservatives.

The bottom line: - The baby electrolyte market is moving from a niche infant-care category toward a broader growth market driven by health awareness, product innovation and regional demand shifts.